Royal Bank of Canada
LUNG icon

Royal Bank of Canada’s Pulmonx LUNG Stock Holding History

Royal Bank of Canada’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Buy
4,047
+2,983
+280% +$4.93K ﹤0.01% 6428
2025
Q4 		$3K Buy
1,064
+656
+161% +$1.23K ﹤0.01% 6836
2025
Q3 		$1K Sell
408
-7,234
-95% -$15.1K ﹤0.01% 6999
2025
Q2 		$19K Buy
7,642
+6,252
+450% +$24.7K ﹤0.01% 6282
2025
Q1 		$9K Sell
1,390
-1,850
-57% -$13.1K ﹤0.01% 6192
2024
Q4 		$22K Sell
3,240
-2,300
-42% -$15.1K ﹤0.01% 6071
2024
Q3 		$46K Buy
5,540
+1,893
+52% +$13.7K ﹤0.01% 5741
2024
Q2 		$24K Buy
3,647
+657
+22% +$5.05K ﹤0.01% 5994
2024
Q1 		$28K Sell
2,990
-10,653
-78% -$125K ﹤0.01% 5778
2023
Q4 		$174K Buy
13,643
+9,051
+197% +$94.3K ﹤0.01% 5224
2023
Q3 		$47K Buy
4,592
+1,500
+49% +$17.4K ﹤0.01% 5816
2023
Q2 		$41K Buy
3,092
+1,175
+61% +$14.4K ﹤0.01% 5871
2023
Q1 		$21K Sell
1,917
-4,281
-69% -$42.3K ﹤0.01% 6011
2022
Q4 		$52K Buy
6,198
+5,781
+1,386% +$55K ﹤0.01% 5856
2022
Q3 		$7K Buy
417
+225
+117% +$4.14K ﹤0.01% 6596
2022
Q2 		$3K Sell
192
-1,413
-88% -$29.1K ﹤0.01% 6838
2022
Q1 		$40K Sell
1,605
-3,912
-71% -$101K ﹤0.01% 6239
2021
Q4 		$177K Buy
5,517
+2,942
+114% +$107K ﹤0.01% 5448
2021
Q3 		$93K Buy
2,575
+736
+40% +$29K ﹤0.01% 5751
2021
Q2 		$81K Buy
1,839
+976
+113% +$42.5K ﹤0.01% 5740
2021
Q1 		$40K Buy
863
+469
+119% +$26.9K ﹤0.01% 6022
2020
Q4 		$27K Buy
+394
New +$19.3K ﹤0.01% 5927

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's LUNG Position: Q1 2026 in Review

Royal Bank of Canada increased its Pulmonx (LUNG) stake by 280% in Q1 2026, buying an estimated $4.93K and bringing the position to 4,047 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6428.

Royal Bank of Canada first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $177K in Q4 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Royal Bank of Canada held 4,047 shares of Pulmonx worth $5K as of Q1 2026.
  • Royal Bank of Canada bought 2,983 Pulmonx shares in Q1 2026, an estimated $4.93K.
  • Pulmonx made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6428 holding.
  • Royal Bank of Canada first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's Pulmonx position peaked at $177K in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.